Company / Revenue
AbCellera Biologics Inc. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$75.1M
FY2025
5-year range
$11.6M / $233.2M
FY2021-FY2025
Trend
+160.6%
vs FY2024
Sector context
#112 of 155
Health Care
What the data says
At $75M, AbCellera Biologics Inc.'s revenue ranks #112 of 155 in the Health Care sector. Revenue returned to growth in FY2025 after 2 years of decline, reaching $75M.
Based on SEC 10-K filings.
$75M in FY2025 with a 5-year CAGR of -20.3%.
Improved from $38M to $75M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -31.4%
- 5-Year CAGR
- -20.3%
- 10-Year CAGR
- -
Sector benchmark
#112 of 155 in Health CareTop 72% of 155This company $75.1M Sector average $4.5B
▼
-98.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -20.3%, indicating a declining trend.
- In FY2025, revenue increased 160.6% year-over-year.
- Ranks #112 out of 155 companies in the Health Care sector.
- Peak revenue was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $75.1M | +160.6% |
| FY2024 | $28.8M | -24.2% |
| FY2023 | $38.0M | -83.7% |
| FY2022 | $233.2M | +1907.9% |
| FY2021 | $11.6M | -95.0% |
| FY2020 | $233.2M | +1907.9% |
| FY2019 | $11.6M | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026